Showing results (71-80 of 91) with videos related to
Sort By:
Pageof 10
The British Journal of Cancer. Supplement|July 1, 1996
Nitric oxide involvement in the toxicity of hydroxyguanidine in leukaemia HL60 cellsS A Everett, K A Smith, K B Patel, et al.Biochemical Pharmacology|February 18, 1992
Uptake and cytotoxicity of novel nitroimidazole-polyamine conjugates in Ehrlich ascites tumour cellsJ Holley, A Mather, P Cullis, et al.Free Radical Biology & Medicine|January 22, 1998
Oxidative denitrification of the antitumour drug hydroxyguanidineS A Everett, K B Patel, M F Dennis, et al.International Journal of Radiation Oncology, Biology, Physics|October 5, 2001
Influence of plasma glutathione levels on radiation mucositisP Wardman, L K Folkes, S M Bentzen, et al.Radiation Research|March 1, 1997
Measurement of tumor oxygenation: a comparison between polarographic needle electrodes and a time-resolved luminescence-based optical sensorD R Collingridge, W K Young, B Vojnovic, et al.International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Radiosensitization by non-nitro compoundsP Wardman, R F Anderson, R J Hodgkiss, et al.Biochemical Pharmacology|February 15, 1991
Fluorescent markers for hypoxic cells. A study of novel heterocyclic compounds that undergo bio-reductive bindingR J Hodgkiss, A C Begg, R W Middleton, et al.Archives of Disease in Childhood|March 1, 1996
The wandering spleenC A Maxwell-Armstrong, E D Clarke, T M Tsang, et al.Journal of Medicinal Chemistry|April 25, 1997
Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugsB G Siim, G J Atwell, R F Anderson, et al.Journal of Medicinal Chemistry|July 1, 1991
Fluorescent markers for hypoxic cells: a study of nitroaromatic compounds, with fluorescent heterocyclic side chains, that undergo bioreductive bindingR J Hodgkiss, G W Jones, A Long, et al.Pageof 10